Published in
Elsevier, Journal of Hepatology, 3(70), p. 483-493, 2019
DOI: 10.1016/j.jhep.2018.10.035
Links
Tools
Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
Journal article published in 2019 by
Gideon M. Hirschfield 
,
Olivier Chazouillères,
Joost P. Drenth,
Douglas Thorburn,
Stephen A. Harrison,
Charles S. Landis ,
Marlyn J. Mayo,
Andrew J. Muir,
James F. Trotter,
Diana J. Leeming,
Morten A. Karsdal ,
Mark J. Jaros,
Lei Ling,
Kathline H. Kim,
Stephen J. Rossi
and other authors.
,
Olivier Chazouillères,
Joost P. Drenth,
Douglas Thorburn,
Stephen A. Harrison,
Charles S. Landis ,
Marlyn J. Mayo,
Andrew J. Muir,
James F. Trotter,
Diana J. Leeming,
Morten A. Karsdal ,
Mark J. Jaros,
Lei Ling,
Kathline H. Kim,
Stephen J. Rossi
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 